US Bancorp’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513 | Hold |
58
| – | – | ﹤0.01% | 3995 |
|
|
2025
Q1 | $627 | Hold |
58
| – | – | ﹤0.01% | 4009 |
|
|
2024
Q4 | $746 | Hold |
58
| – | – | ﹤0.01% | 3981 |
|
|
2024
Q3 | $1.61K | Hold |
58
| – | – | ﹤0.01% | 3814 |
|
|
2024
Q2 | $1.69K | Hold |
58
| – | – | ﹤0.01% | 3722 |
|
|
2024
Q1 | $2.6K | Buy |
+58
| New | +$2.6K | ﹤0.01% | 3656 |
|
|
2023
Q4 | – | Sell |
-118
| Closed | -$3.47K | – | 4045 |
|
|
2023
Q3 | $3.47K | Hold |
118
| – | – | ﹤0.01% | 3520 |
|
|
2023
Q2 | $7.51K | Buy |
118
+76
| +181% | +$4.84K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $1.96K | Buy |
42
+5
| +14% | +$234 | ﹤0.01% | 3740 |
|
|
2022
Q4 | $2.6K | Buy |
+37
| New | +$2.6K | ﹤0.01% | 3692 |
|